ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effect of m6A methyltransferase METTL3-mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer

Li, Sumei; Jiang, Fengru; Chen, Feiyu; Deng, Yingzhao; Pan, Xiaoping*南方医科大学
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY2022-1DOI: 10.1002/jbt.22922
17被引11阅读
引用收藏
分享

摘要

N6-methyladenosine (m6A) methyltransferase METTL3 has been implicated in carcinogenesis, which may be associated the overexpression of MALAT1. However, the downstream mechanics actions remain largely unknown. This study intends to probe the downstream mechanism of the N6-methyladenosine (m(6)A) methyltransferase METTL3 and MALAT1 in adriamycin resistance in breast cancer. Through Bioinformatics databases lncMAP, TCGA and GTEx, we predicted the downstream transcription factors E2F1 and AGR2 of MALAT1 in breast cancer. The Cancer Genome Atlas and Genotype-Tissue Expression (GTEx) databases were used to screen the downstream target genes of MALAT1. MeRIP-qPCR was used to detect the m(6)A level of MALAT1 in cells. RIP was used to detect the binding between MALAT1 and E2F1, and chromatin immunoprecipitation (ChIP) for the binding of E2F1 to AGR2 promoter. Cell Counting Kit-8 and colony formation assays were used to detect cell viability. Transwell was used to detect cell invasion. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blot were used to detect the expression of related genes and proteins. A nude mouse xenograft tumor model was established to observe the effect of METTL3 on adriamycin resistance of breast cancer. The total survival of mice after exogenous gene silencing was analyzed by the Kaplan-Meier method. METTL3 was highly expressed in adriamycin-resistant breast cancer cells. METTL3 promotes adriamycin resistance in breast cancer cells. METTL3 mediates the expression of MALAT1 in adriamycin-resistant breast cancer through m(6)A. MALAT1 increases adriamycin resistance in breast cancer cells by recruiting E2F1 to activate AGR2 transcription. METTL3 can regulate the expression of MALAT1 through m(6)A, mediate the E2F1/AGR2 axis, and promote the adriamycin resistance of breast cancer. METTL3 may modify MALAT1 protein through m(6)A, recruit E2F1 and activate downstream AGR2 expression, thus promoting adriamycin resistance in breast cancer.

学科与关键词

关键词
adriamycin resistanceanterior gradient 2breast cancerm(6)Amethyltransferasemethyltransferase-like 3MALAT1
相关
加载中…
  • METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner
    Pan, Xiaoping*; Hong, Xiaolv; Li, Sumei; Meng, Ping; Xiao, FengExperimental and Molecular Medicine, 2021, 53(1): 91-102.被引 73
  • METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m6A Modification
    Hu, Shaojun; Song, Yang; Zhou, Yu; Jiao, Yu; Li, Guopeng*Journal of Healthcare Engineering, 2022, 2022: 5794422.被引 6
  • The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer
    Xu, Youqin; Song, Mu; Hong, Ziyang; Chen, Wancheng; Zhang, Qianbing; Zhou, Jianlong; Yang, Chao; He, Zilong; Yu, Juanjuan; Peng, Xiaolin; Zhu, Qiuhong; Li, Shaotian; Ji, Kaiyuan*; Liu, Minfeng*; Zuo, Qiang*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42(1): 10.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
发表日期
2022-01
卷期
第 36 卷, 第 1 期
页码
e22922
DOI
10.1002/jbt.22922
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • L

    Li, Sumei (第一作者)

    southern med univ

  • J

    Jiang, Fengru

    southern med univ

查看全部 5 位作者收起作者
  • C

    Chen, Feiyu

    southern med univ

  • D

    Deng, Yingzhao

    southern med univ

  • P

    Pan, Xiaoping (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417